Autenrieth, M;Muendel, R;Lienau, B;Kron, M;Gschwend, JE;Herkommer, KAre there contraindications for a curative treatment of prostate cancer patients >= 75 years with regard to quality of life?Eur Urol200873917 -
Gschwend, JE;n.a.Local advanced bladder cancer: After chemotherapy: Observation strategy instead of cystectomyAktuelle Urol2008394249-250
Treiber, U;Souvatzoglou, M;Tuncel, M;Maurer, T;Kuebler, H;Zantl, N;Praus, C;Geinitz, H;Gschwend, JE;Schwaiger, M;Krause, BJEfficacy of 11C-Choline PET/CT for detection of recurrence in patients with rising PSA after radical prostatectomyEur Urol200873853 -
Köttgen, M;Buchholz, B;Garcia-Gonzalez, MA;Kotsis, F;Fu, X;Doerken, M;Boehlke, C;Steffl, D;Tauber, R;Wegierski, T;Nitschke, R;Suzuki, M;Kramer-Zucker, A;Germino, GG;Watnick, T;Prenen, J;Nilius, B;Kuehn, EW;Walz, GTRPP2 and TRPV4 form a polymodal sensory channel complex.J Cell Biol20081823437-47
Kusmartsev, S;Eruslanov, E;Kubler, H;Tseng, T;Sakai, Y;Su, Z;Kaliberov, S;Heiser, A;Rosser, C;Dahm, P;Siemann, D;Vieweg, JOxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.J Immunol20081811346-53
Retz, M;Hartmann, A;Merseburger, A;Olbert, P;Stoehr, R;Nawroth, R[German Association for Bladder Cancer Research]Urologe A20084791141-2, 1144
Kubler, H;Gschwend, JE[Active immunotherapy of urologic malignancies and tumor-mediated immunosuppression]Urologe A20084791122-7
Vogler, M;Walczak, H;Stadel, D;Haas, TL;Genze, F;Jovanovic, M;Gschwend, JE;Simmet, T;Debatin, KM;Fulda, STargeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.Cancer Res200868197956-65
Nawroth, R;Stöhr, R;Hartmann, A;Gschwend, JE;Retz, M[EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]Urologe A20084791152-6
Scales, CD;Voils, CI;Fesperman, SF;Sur, RL;Kubler, H;Preminger, GM;Dahm, PBarriers to the practice of evidence-based urology.J Urol200817962345-9; discussion 2349-5